Why QA Is Ireland’s Pharma Superpower
Ireland is a global pharmaceuticals leader, home to major multinationals, world-class biopharma facilities, and billions in annual exports. But beneath the labs, reactors, and cleanrooms, one function quietly safeguards this entire ecosystem: Quality Assurance. QA professionals don’t just ensure compliance – they protect Ireland’s reputation as a trusted, reliable manufacturing hub. And as the […]
Pharma’s Shift Toward Continuous Improvement
Pharmaceutical and biotech companies are ramping up continuous improvement (CI) efforts — moving beyond isolated efficiency projects to embed process excellence, digitalisation, and a culture of ongoing refinement into their core strategies. Key Drivers Behind the Shift 1. Automation & Real-Time Monitoring The pandemic accelerated automation adoption—from robotics on the manufacturing floor to real-time […]
Impact of Project Controls Talent Shortage on Pharma Capital Projects
The pharmaceutical industry is experiencing a significant shortage of project controls professionals with industry-specific expertise. This scarcity is increasingly affecting the successful delivery of capital investment construction projects for the sector’s top investors. As pharmaceutical companies ramp up investments in facilities to meet rising demand for innovative therapies, vaccines, and biologics, the lack of specialized […]
7 Ways the New Budget will Impact the Pharmaceutical Industry
With every budget cycle, governments outline policies and allocate resources that can significantly impact the Pharmaceutical industry. Below are 7 ways in which the new budget will affect the pharmaceutical industry, including key allocations, policy changes, and anticipated challenges or opportunities. 1. Increased R&D Funding A standout feature of the new budget is its […]
Increase in Biotech Funding – 2023 to 2024
The biotech sector has witnessed a notable resurgence in funding from 2023 to 2024, after a challenging period characterized by macroeconomic pressures and declining venture capital (VC) investments in 2022 and early 2023. In 2024, investor confidence has started to recover, fueled by several factors including government incentives, industry partnerships, and emerging market stabilization. Several […]
2023 vs. 2024: Industry Confidence in CAPEX Pharmaceutical Investment
Capital expenditure (CAPEX) in the pharmaceutical industry is a critical indicator of companies’ commitment to innovation, capacity expansion, and long-term growth. Over the past year, the landscape of CAPEX investment in pharmaceuticals has evolved, driven by factors such as advancements in biotechnology, the demand for new therapies, regulatory changes, and global economic shifts. This article […]
The Impending Windsor Framework’s Impact on the Pharmaceutical Industry
The Impending Windsor Framework’s Impact on the Pharmaceutical Industry: What UK Pharma Businesses Need to Prepare for by January 2025 As the January 2025 deadline for the implementation of the Windsor Framework approaches, the pharmaceutical industry in the United Kingdom faces a significant shift in its operational landscape. The Windsor Framework, which was established to […]
8 Benefits of Using Contractors/Freelancers within the Clinical Trials Space
The Pharmaceutical and Life Science industry is dynamic, fast-paced, and heavily regulated, with clinical trials playing a central role in advancing medical research and bringing new treatments to market. To navigate the complexities and stringent demands of clinical trials, many companies are increasingly turning to contractors and freelancers. This strategic shift offers numerous benefits, including […]
How Digital Validation is Changing the Pharma Industry
The Pharmaceutical industry stands on the brink of a significant transformation, driven by the advent of digital validation. Traditionally, drug development and validation processes have been laborious, time-consuming, and often laden with inefficiencies. However, with advancements in digital technology, the landscape is rapidly evolving, promising streamlined processes, enhanced efficiency, and improved patient outcomes. This article […]